AstraZeneca slides even as the company's coronavirus vaccine trial results show 'promise'

"These early results hold promise," Sarah Gilbert, the University of Oxford professor leading the research on the vaccine ...
Reuters

AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costs

stra(Reuters) - AstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be ...
Reuters

Oxford Biomedica lifts outlook as AstraZeneca ramps up vaccine output

(Reuters) - Oxford Biomedica on Tuesday doubled the revenue expectation from its COVID-19 vaccine supply deal with AstraZeneca after the drugmaker commissioned more batches from the company in the ...
Homeland Security Today

AstraZeneca Receives First Commitments for Oxford’s Potential New COVID-19 Vaccine

A USAMRIID employee harvests samples of the virus that causes COVID-19 which will be used to develop models of infection, additional diagnostic tests, and medical countermeasures to include vaccines ...
Medscape

UK Regulators to Offer Under-30s Alternative to AZ COVID Vaccine

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Adults under 30 years of age will be offered an alternative vaccine to the AstraZeneca/Oxford ...
The Press

Third shot of Oxford/AstraZeneca vaccine ‘could be effective booster’

A third shot of the Oxford/AstraZeneca vaccine could be an effective booster jab without the need for tweaks, new research suggests. An Oxford University study found that giving people a third dose ...
Sky

COVID-19: Germany, France, Italy and Spain pause Oxford-AstraZeneca coronavirus vaccine amid blood clot concerns

Germany, France, Italy and Spain are suspending use of the Oxford-AstraZeneca coronavirus vaccine as EU regulators investigate reports some people developed blood clots after having the jab. The ...